‘Currently, the law states that all abortion pills must be taken in a clinic or hospital – meaning some women end up having an abortion on public transport, or while driving home.’
Rights Info, 31st July 2018
Source: rightsinfo.org
‘Cases of Billy Caldwell and Alfie Dingley, who have severe epilepsy, along with lobbying, prompted change.’
The Guardian, 26th July 2018
Source: www.theguardian.com
‘The Home Secretary today announced a review into the scheduling of cannabis for medicinal purposes.’
Home Office, 19th June 2018
Source: www.gov.uk/home-office
‘The government has said it will review the use of medicinal cannabis, although recreational usage will still be illegal.’
BBC News, 19th June 2018
Source: www.bbc.co.uk
‘A four-year inquiry into the deaths of hundreds of elderly people who were routinely prescribed opioid drugs is expected to say that blame lies not just with the doctor involved but also those who worked with her, failed to monitor her and who failed to investigate – including the government.’
The Guardian, 20th June 2018
Source: www.theguardian.com
‘Private Client analysis: Alex Ruck Keene, barrister, of 39 Essex Chambers, examines the decision of the Court of Protection in Re AB [2016] EWCOP 66 to approve deceiving a person lacking mental capacity in order to administer her medication.’
Family Law, 19th April 2018
Source: www.familylaw.co.uk
‘Manufacturers of branded medicines face new statutory controls on the cost of their drugs to the NHS in the UK from 1 April.’
OUT-LAW.com, 13th March 2018
Source: www.out-law.com
‘Daptomycin is an antibiotic used to treat systemic and life-threatening infections caused by multiple drug resistant bacteria. Its effectiveness depends on its purity. The invention for which the patent in suit was granted was a way of purifying the antibiotic. In Hospira UK Ltd v Cubist Pharmaceuticals LLC [2016] EWHC 1285 (Pat) (10 June 2016), Hospira UK Ltd, (a British subsidiary of Pfizer) sought the revocation of that patent. Mr Justice Henry Carr found that the patent was invalid and ordered its revocation. Cubist Pharmaceuticals LLC (a subsidiary of Merck & Co.) appealed against that judgment and order in Hospira UK Ltd v Cubist Pharmaceuticals LLC [2018] EWCA Civ 12 (18 Jan 2018).’
NIPC Law, 24th January 2018
Source: nipclaw.blogspot.co.uk
‘Two drug giants are threatening to take the NHS to court for plans to offer patients cheap treatment to prevent blindness.’
Daily Telegraph, 1st November 2017
Source: www.telegraph.co.uk
‘Body modification artists have been exposed carrying out illegal and potentially dangerous tongue splitting procedures.’
BBC News, 9th October 2017
Source: www.bbc.co.uk
‘Medical experts were “complicit” in allowing thousands of children to suffer deformity after resisting warnings on epilepsy drugs, campaigners have said.’
Daily Telegraph, 26th September 2017
Source: www.telegraph.co.uk
‘Laughing gas could still be legal after a judge dismissed a case, saying the drug is not covered by a law which bans “legal highs”.’
The Independent, 31st August 2017
Source: www.independent.co.uk
‘Rosalind English discusses with David Hart QC a recent challenge to the refusal by the NHS to fund a specialist drug for a child suffering from a metabolic condition.’
Law Pod UK, 17th August 2017
Source: audioboom.com
‘The family of a seven-year-old boy whose condition could cause brain damage have won a High Court challenge over an NHS decision not to fund a life-changing drug.’
BBC News, 8th August 2017
Source: www.bbc.co.uk
‘Supreme Court (Lords Neuberger, Mance, Clarke, Sumption and Hodge) Eli Lilly v Actavis UK Ltd and others [2017] UKSC 48 (12 July 2017)
What the Appeal was about
The pharmaceutical company Eli Lilly and Co (“Lilly”) has developed a drug called pemetrexed which it markets under the brand name Alimta for the treatment of various types of cancer. Used on its own, pemetrexed has unpleasant side effects that can sometimes be fatal but these can be avoided when it is administered as a compound called pemetrexed disodium in combination with vitamin B12.’
NIPC Law, 13th July 2017
Source: nipclaw.blogspot.co.uk
‘British pharmaceutical companies are suing the NHS’s drugs watchdog in an effort to prevent drug rationing.’
Daily Telegraph, 10th July 2017
Source: www.telegraph.co.uk
‘BT was found deceased by her partner and carer, S, on the morning of 5th June 2016.
She had an extremely complicated medical history that included diabetes, obstructive sleep apnoea, schizoaffective disorder and dissociative disorder, epilepsy, migraines and asthma.’
Park Square Barristers, 27th June 2017
Source: www.parksquarebarristers.co.uk
‘After years of limited focus on ‘excessive pricing’, in December 2016 the Competition and Markets Authority (CMA) took one decision finding that such an abuse of dominance had occurred, and issued a statement of objections in another case. Does this reflect a broad policy shift, or a reaction to specific cases of perceived opportunistic behaviour?’
Law Society's Gazette, 12th June 2017
Source: www.lawgazette.co.uk
‘A drug company was entitled to rely on its trade mark rights to stop two businesses from importing into the UK the same product as it sold on the basis that the rivals’ product would be sold under the drug company’s name, the Court of Appeal in London has ruled.’
OUT-LAW.com, 6th April
Source: www.out-law.com
© Inner Temple Library 2025